Altimmune Inc (ALT)
7.36
+0.06
(+0.82%)
USD |
NASDAQ |
May 06, 16:00
7.30
-0.06
(-0.82%)
Pre-Market: 08:46
Altimmune 1 Year Total Returns (Daily): 48.99% for May 6, 2024
1 Year Total Returns (Daily) Chart
Historical 1 Year Total Returns (Daily) Data
| Date | Value |
|---|---|
| May 06, 2024 | 48.99% |
| May 03, 2024 | 46.59% |
| May 02, 2024 | 51.69% |
| May 01, 2024 | 43.70% |
| April 30, 2024 | 29.70% |
| April 29, 2024 | 26.63% |
| April 26, 2024 | 39.08% |
| April 25, 2024 | 37.67% |
| April 24, 2024 | 28.26% |
| April 23, 2024 | 30.74% |
| April 22, 2024 | 29.02% |
| April 19, 2024 | 15.75% |
| April 18, 2024 | 20.88% |
| April 17, 2024 | 29.17% |
| April 16, 2024 | 57.32% |
| April 15, 2024 | 57.95% |
| April 12, 2024 | 94.40% |
| April 11, 2024 | 102.9% |
| April 10, 2024 | 98.27% |
| April 09, 2024 | 109.5% |
| April 08, 2024 | 114.7% |
| April 05, 2024 | 134.9% |
| April 04, 2024 | 116.0% |
| April 03, 2024 | 110.2% |
| April 02, 2024 | 121.7% |
| Date | Value |
|---|---|
| April 01, 2024 | 142.4% |
| March 28, 2024 | 130.3% |
| March 27, 2024 | 84.44% |
| March 26, 2024 | 100.2% |
| March 25, 2024 | 97.45% |
| March 22, 2024 | 116.2% |
| March 21, 2024 | 84.04% |
| March 20, 2024 | -14.47% |
| March 19, 2024 | -20.62% |
| March 18, 2024 | -17.53% |
| March 15, 2024 | -9.79% |
| March 14, 2024 | -9.60% |
| March 13, 2024 | 1.21% |
| March 12, 2024 | 4.82% |
| March 11, 2024 | -4.82% |
| March 08, 2024 | -5.97% |
| March 07, 2024 | -6.70% |
| March 06, 2024 | -2.23% |
| March 05, 2024 | -3.02% |
| March 04, 2024 | -4.66% |
| March 01, 2024 | 0.33% |
| February 29, 2024 | -3.89% |
| February 28, 2024 | 5.48% |
| February 27, 2024 | 16.74% |
| February 26, 2024 | -5.51% |
Total Return Definition
The Total return is the change in price over a specific period of time that includes dividends and distributions paid.
1 Year Total Returns (Daily) Range, Past 5 Years
-92.02%
Minimum
Sep 23 2019
1.32K%
Maximum
Jul 20 2020
96.53%
Average
-10.67%
Median
Jul 06 2021
1 Year Total Returns (Daily) Benchmarks
| Eli Lilly and Co | 80.70% |
| Amgen Inc | 30.91% |
| Pfizer Inc | -23.01% |
| Viking Therapeutics Inc | 242.1% |
| Precision BioSciences Inc | -58.20% |